Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells - PubMed (original) (raw)
. 2000 Nov 1;165(9):5170-6.
doi: 10.4049/jimmunol.165.9.5170.
K Broliden, R Kaul, L Svensson, K Johansen, P Kiama, J Kimani, L Lopalco, S Piconi, J J Bwayo, F Plummer, M Clerici, J Hinkula
Affiliations
- PMID: 11046049
- DOI: 10.4049/jimmunol.165.9.5170
Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells
C Devito et al. J Immunol. 2000.
Abstract
HIV-1-specific IgA has been described in the genital tract and plasma of HIV-1 highly exposed, persistently seronegative (HEPS) individuals, and IgA from these sites has been shown to neutralize HIV-1. This study examines the ability of IgA isolated from HEPS individuals to inhibit transcytosis across a tight epithelial cell layer. A Transwell system was established to model HIV-1 infection across the human mucosal epithelium. The apical-basolateral transcytosis of primary HIV-1 isolates across this mucosal model was examined in the presence and the absence of IgA isolated from the genital tract, saliva, and plasma of HEPS individuals enrolled in both a sex worker cohort in Nairobi, Kenya, and a discordant couple cohort in Italy. In the absence of IgA, HIV-1 primary isolates were actively transported across the epithelial membrane and were released on the opposite side of the barrier. These transcytosed HIV-1 particles retained their ability to infect human mononuclear cells. However, IgA purified from the mucosa and plasma of HEPS individuals was able to inhibit HIV-1 transcytosis. Inhibition was seen in three of six cervicovaginal fluid samples, five of 10 saliva samples, and three of six plasma samples against at least one of the two primary HIV-1 isolates tested. IgA from low risk, healthy control subjects had no inhibitory effect on HIV-1 transcytosis. The ability of mucosal and plasma IgA to inhibit HIV-1 transcytosis across the mucosal epithelium may represent an important mechanism for protection against the sexual acquisition of HIV-1 infection in HEPS individuals.
Similar articles
- Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers.
Broliden K, Hinkula J, Devito C, Kiama P, Kimani J, Trabbatoni D, Bwayo JJ, Clerici M, Plummer F, Kaul R. Broliden K, et al. Immunol Lett. 2001 Nov 1;79(1-2):29-36. doi: 10.1016/s0165-2478(01)00263-2. Immunol Lett. 2001. PMID: 11595287 - Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects.
Devito C, Hinkula J, Kaul R, Kimani J, Kiama P, Lopalco L, Barass C, Piconi S, Trabattoni D, Bwayo JJ, Plummer F, Clerici M, Broliden K. Devito C, et al. J Acquir Immune Defic Syndr. 2002 Aug 1;30(4):413-20. doi: 10.1097/00042560-200208010-00007. J Acquir Immune Defic Syndr. 2002. PMID: 12138348 - Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate.
Devito C, Hinkula J, Kaul R, Lopalco L, Bwayo JJ, Plummer F, Clerici M, Broliden K. Devito C, et al. AIDS. 2000 Sep 8;14(13):1917-20. doi: 10.1097/00002030-200009080-00006. AIDS. 2000. PMID: 10997395 - Neutralizing antibodies in mucosal secretions: IgG or IgA?
Alexander R, Mestecky J. Alexander R, et al. Curr HIV Res. 2007 Nov;5(6):588-93. doi: 10.2174/157016207782418452. Curr HIV Res. 2007. PMID: 18045115 Review.
Cited by
- Exploring Immunome and Microbiome Interplay in Reproductive Health: Current Knowledge, Challenges, and Novel Diagnostic Tools.
Lingasamy P, Modhukur V, Mändar R, Salumets A. Lingasamy P, et al. Semin Reprod Med. 2023 Sep;41(5):172-189. doi: 10.1055/s-0043-1778017. Epub 2024 Jan 23. Semin Reprod Med. 2023. PMID: 38262441 Free PMC article. Review. - Natural Immunity against HIV-1: Progression of Understanding after Association Studies.
Luo M. Luo M. Viruses. 2022 Jun 8;14(6):1243. doi: 10.3390/v14061243. Viruses. 2022. PMID: 35746714 Free PMC article. Review. - Variable-heavy (VH) families influencing IgA1&2 engagement to the antigen, FcαRI and superantigen proteins G, A, and L.
Ling WL, Su CT, Lua WH, Yeo JY, Poh JJ, Ng YL, Wipat A, Gan SK. Ling WL, et al. Sci Rep. 2022 Apr 20;12(1):6510. doi: 10.1038/s41598-022-10388-5. Sci Rep. 2022. PMID: 35444201 Free PMC article. - Impact of Caveolin-Mediated Endocytosis on the Trafficking of HIV within the Colonic Barrier.
Anwar A, Helou M, Hervol J, Levine AD. Anwar A, et al. J Virol. 2022 Apr 13;96(7):e0020222. doi: 10.1128/jvi.00202-22. Epub 2022 Mar 17. J Virol. 2022. PMID: 35297667 Free PMC article. - Vaccine with bacterium-like particles displaying HIV-1 gp120 trimer elicits specific mucosal responses and neutralizing antibodies in rhesus macaques.
Wang H, Li P, Zhang M, Bi J, He Y, Li F, Yu R, Gao F, Kong W, Yu B, Chen L, Yu X. Wang H, et al. Microb Biotechnol. 2022 Jul;15(7):2022-2039. doi: 10.1111/1751-7915.14022. Epub 2022 Mar 15. Microb Biotechnol. 2022. PMID: 35290714 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous